BCPC · XBRL financial data

Balchem financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BCPC's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Revenue from contracts with customers	229	240	234	240	240	251	255	268	264	271	284	291
Cost of revenue	154*	158	151	155	154*	162	162	172	170*	170	180	185
Gross profit	75	82	83	85	86	88	93	95	94	101	104	106
Research and development	4*	4	4	4	5*	5	4	4	5*	6	5	5
General and administrative	13*	18	15	17	17*	16	18	17	17*	18	19	17
Total operating expenses	37*	40	37	37	39*	37	42	41	42*	45	44	43
Operating income (loss)	38*	42	46	48	47*	51	51	55	52*	56	59	62
Other income (expense)	0*	1	(0)	(0)	(0)*	(0)	0	0	(0)*	(1)	0	(0)
Income tax expense (benefit)	7*	8	9	10	11*	11	11	12	11*	12	13	13
Net income (loss)	27	29	32	34	34	37	38	40	39	40	45	47
Earnings per share, basic USD per share	0.83	0.90	0.99	1.05	1.05	1.14	1.18	1.25	1.23	1.26	1.40	1.47
Earnings per share, diluted USD per share	0.82	0.89	0.98	1.03	1.03	1.13	1.17	1.24	1.21	1.25	1.39	1.46
Weighted average shares, basic millions of shares	32*	32	32	32	32*	32	32	32	32*	32	32	32
Weighted average shares, diluted millions of shares	32*	33	33	33	33*	33	33	33	32*	32	32	32

Fiscal quarters (BCPC's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	64	60	64	74	50	50	65	65	75	73	63	66
Accounts receivable	125	140	123	121	120	130	136	132	144	154	149	146
Inventory	110	110	117	119	131	145	148	132	131	147	162	177
Total current assets	314	325	320	326	314	340	365	344	366	389	388	405
Property and equipment, net	276	274	273	277	282	284	290	298	307	303	305	306
Right-of-use asset	18	17	16	16	15	16	16	16	15	14	13	16
Goodwill	779	772	770	781	780	793	816	816	816	811	809	807
Total assets	1,597	1,589	1,575	1,597	1,575	1,618	1,678	1,661	1,686	1,694	1,687	1,704
Accrued liabilities	41	38	37	40	44	44	48	49	49	52	52	59
Total current liabilities	148	124	113	109	158	140	138	126	176	153	146	164
Lease liability, non-current	15	14	14	13	13	12	12	12	11	11	10	13
Total liabilities	543	510	463	420	425	409	410	363	429	409	385	377
Retained earnings	897	926	959	992	997	1,035	1,073	1,113	1,121	1,162	1,206	1,253
Total stockholders' equity	1,054	1,079	1,112	1,177	1,150	1,209	1,268	1,298	1,257	1,285	1,302	1,327
Total liabilities and equity	1,597	1,589	1,575	1,597	1,575	1,618	1,678	1,661	1,686	1,694	1,687	1,704
Common shares outstanding (cover page) millions of shares	32	32	32	33	33	33	32	32	32	32	32	32

Fiscal quarters (BCPC's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	27	29	32	34	34	37	38	40	39	40	45	47
Stock-based compensation	4*	5	4*	4*	4*	4	6*	5*	4*	5	6*	5*
Depreciation and amortization	14*	14	13	11	11*	11	11	12	12*	12	12	12
Net cash from operating activities	67*	33	45*	51*	52*	36	47*	66*	67*	40	47*	70*
Net cash from investing activities	(12)*	(7)	(7)*	(9)*	(37)*	(6)	(7)*	(15)*	(16)*	(6)	(11)*	(13)*
Share repurchases	0*	5	0*	0*	0*	5	33*	15*	54*	16	29*	27*
Dividends paid	0*	26	0*	0*	0*	28	0*	0*	0*	31	0*	0*
Net cash from financing activities	(70)*	(30)	(34)*	(34)*	(35)*	(32)	(29)*	(51)*	(41)*	(35)	(45)*	(54)*
Net change in cash	(13)*	(4)	3*	10*	(24)*	0	16*	(0)*	9*	(2)	(10)*	3*

SIC 2800 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2800 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Balchem	66	291	70*	31.8M	—	Q3 FY26 10-QSep 30, 2026
FMC	736	106	6.6*	155.6M	—	Q3 FY26 10-QSep 30, 2026
OLIN	215	1,748	110*	114.0M	—	Q3 FY26 10-QSep 30, 2026
Perimeter Solutions	83	214	(0.7)*	163.7M	126.6 quarters	Q2 FY26 10-QJun 30, 2026
Huntsman	359	1,717	not reported	175.3M	—	Q3 FY26 10-QSep 30, 2026
Chemours	671	1,591	158*	150.5M	—	Q2 FY26 10-QJun 30, 2026
Ingevity	97	314	(14)*	34.4M	7.1 quarters	Q2 FY26 10-QJun 30, 2026
Solstice Advanced Materials	750	1,148	262*	158.8M	—	Q2 FY26 10-QJun 30, 2026
Innospec	250	491	7.2*	24.6M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.